Report Detail
Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Professional Survey Report 2019
- RnM3773334 |
- 23 September, 2019 |
- Global |
- 109 Pages |
- QYResearch |
- Other
High potency active pharmaceutical ingredients are used in targeted therapeutics and show effective treatment even at extremely low concentration. These APIs are difficult to manufacture and require technological expertise and sophisticated manufacturing setup. HPAPI market currently accounts for a small portion of overall API market, however is a rapidly growing segment.
The global HPAPI (High Potency Active Pharmaceutical Ingredients) market was valued at 16600 million US$ in 2018 and will reach 32200 million US$ by the end of 2025, growing at a CAGR of 8.7% during 2019-2025.
This report focuses on HPAPI (High Potency Active Pharmaceutical Ingredients) volume and value at global level, regional level and company level. From a global perspective, this report represents overall HPAPI (High Potency Active Pharmaceutical Ingredients) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of HPAPI (High Potency Active Pharmaceutical Ingredients) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their HPAPI (High Potency Active Pharmaceutical Ingredients) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Alkermes
Cambrex
Dishman
Dr. Reddy’S
Lonza
Novasep
Thermofisher Scientific
Pfizer
Merck
Teva Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Innovative HPAPI
Generic HPAPI
Segment by Application
Captive HPAPI
Merchant HPAPI
Table of Contents
Executive Summary
1 Industry Overview of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 1.1 Definition of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 1.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment by Type
- 1.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Innovative HPAPI
- 1.2.3 Generic HPAPI
- 1.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment by Applications
- 1.3.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Comparison by Applications (2014-2025)
- 1.3.2 Captive HPAPI
- 1.3.3 Merchant HPAPI
- 1.4 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Overall Market
- 1.4.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue (2014-2025)
- 1.4.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production (2014-2025)
- 1.4.3 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Status and Prospect (2014-2025)
- 1.4.4 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Status and Prospect (2014-2025)
- 1.4.5 China HPAPI (High Potency Active Pharmaceutical Ingredients) Status and Prospect (2014-2025)
- 1.4.6 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Status and Prospect (2014-2025)
- 1.4.8 India HPAPI (High Potency Active Pharmaceutical Ingredients) Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 2.3 Manufacturing Process Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 2.4 Industry Chain Structure of HPAPI (High Potency Active Pharmaceutical Ingredients)
3 Development and Manufacturing Plants Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 3.1 Capacity and Commercial Production Date
- 3.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Production and Capacity Analysis
- 4.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue Analysis
- 4.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Price Analysis
- 4.4 Market Concentration Degree
5 HPAPI (High Potency Active Pharmaceutical Ingredients) Regional Market Analysis
- 5.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Production by Regions
- 5.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production by Regions
- 5.1.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue by Regions
- 5.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Regions
- 5.3 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
- 5.3.1 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Production
- 5.3.2 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Import and Export
- 5.4 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
- 5.4.1 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Production
- 5.4.2 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Import and Export
- 5.5 China HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
- 5.5.1 China HPAPI (High Potency Active Pharmaceutical Ingredients) Production
- 5.5.2 China HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China HPAPI (High Potency Active Pharmaceutical Ingredients) Import and Export
- 5.6 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
- 5.6.1 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Production
- 5.6.2 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Import and Export
- 5.7 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
- 5.7.1 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Production
- 5.7.2 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Import and Export
- 5.8 India HPAPI (High Potency Active Pharmaceutical Ingredients) Market Analysis
- 5.8.1 India HPAPI (High Potency Active Pharmaceutical Ingredients) Production
- 5.8.2 India HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India HPAPI (High Potency Active Pharmaceutical Ingredients) Import and Export
6 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment Market Analysis (by Type)
- 6.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production by Type
- 6.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue by Type
- 6.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Price by Type
7 HPAPI (High Potency Active Pharmaceutical Ingredients) Segment Market Analysis (by Application)
- 7.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
- 7.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Market Share by Application (2014-2019)
8 HPAPI (High Potency Active Pharmaceutical Ingredients) Major Manufacturers Analysis
- 8.1 Alkermes
- 8.1.1 Alkermes HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.1.2 Alkermes Product Introduction, Application and Specification
- 8.1.3 Alkermes HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Cambrex
- 8.2.1 Cambrex HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.2.2 Cambrex Product Introduction, Application and Specification
- 8.2.3 Cambrex HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Dishman
- 8.3.1 Dishman HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.3.2 Dishman Product Introduction, Application and Specification
- 8.3.3 Dishman HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Dr. Reddy’S
- 8.4.1 Dr. Reddy’S HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.4.2 Dr. Reddy’S Product Introduction, Application and Specification
- 8.4.3 Dr. Reddy’S HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Lonza
- 8.5.1 Lonza HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.5.2 Lonza Product Introduction, Application and Specification
- 8.5.3 Lonza HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Novasep
- 8.6.1 Novasep HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.6.2 Novasep Product Introduction, Application and Specification
- 8.6.3 Novasep HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Thermofisher Scientific
- 8.7.1 Thermofisher Scientific HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.7.2 Thermofisher Scientific Product Introduction, Application and Specification
- 8.7.3 Thermofisher Scientific HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Pfizer
- 8.8.1 Pfizer HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.8.2 Pfizer Product Introduction, Application and Specification
- 8.8.3 Pfizer HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Merck
- 8.9.1 Merck HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.9.2 Merck Product Introduction, Application and Specification
- 8.9.3 Merck HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Teva Pharmaceutical
- 8.10.1 Teva Pharmaceutical HPAPI (High Potency Active Pharmaceutical Ingredients) Production Sites and Area Served
- 8.10.2 Teva Pharmaceutical Product Introduction, Application and Specification
- 8.10.3 Teva Pharmaceutical HPAPI (High Potency Active Pharmaceutical Ingredients) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients) Market
- 9.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trend Analysis
- 9.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Size (Volume and Value) Forecast 2019-2025
- 9.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Regional Market Trend
- 9.2.1 North America HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast 2019-2025
- 9.2.2 Europe HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast 2019-2025
- 9.2.3 China HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast 2019-2025
- 9.2.4 Japan HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast 2019-2025
- 9.2.5 Southeast Asia HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast 2019-2025
- 9.2.6 India HPAPI (High Potency Active Pharmaceutical Ingredients) Forecast 2019-2025
- 9.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trend (Product Type)
- 9.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on HPAPI (High Potency Active Pharmaceutical Ingredients). Industry analysis & Market Report on HPAPI (High Potency Active Pharmaceutical Ingredients) is a syndicated market report, published as Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
